Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...
As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results